Siris Ltd.
BSE: 524746 | Sector: Health care |
NSE: SIRIS | ISIN Code: INE282B01014 |
BSE 05:30 | 01 Jan | Siris Ltd |
NSE 05:30 | 01 Jan | Siris Ltd |
Siris Ltd. (SIRIS) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 609.30 | 146,189.34 | 12,531.93 | 3,211.14 | 32,355.78 |
Divi's Lab. | 3,442.40 | 91,378.51 | 5,310.57 | 1,372.71 | 7,370.84 |
Dr Reddy's Labs | 4,484.00 | 74,568.92 | 11,850.40 | 2,937.70 | 16,732.90 |
Cipla | 808.05 | 65,165.19 | 12,659.15 | 2,318.17 | 17,704.77 |
Aurobindo Pharma | 864.00 | 50,621.76 | 13,266.48 | 1,872.74 | 16,809.46 |
Biocon | 398.85 | 47,862.00 | 1,988.40 | 440.90 | 7,583.50 |
Lupin | 1,023.85 | 46,441.84 | 11,025.66 | 727.55 | 17,937.29 |
Cadila Health. | 438.20 | 44,858.54 | 6,347.40 | 1,412.90 | 15,089.80 |
Apollo Hospitals | 3,088.10 | 44,400.70 | 9,794.50 | 470.30 | 8,570.00 |
Piramal Enterp. | 1,949.00 | 43,959.70 | 4,219.19 | 144.85 | 33,415.39 |
Torrent Pharma. | 2,469.90 | 41,795.65 | 6,168.44 | 938.51 | 10,683.66 |
Gland Pharma | 2,409.90 | 39,401.87 | 2,633.24 | 772.86 | 3,653.86 |
Alkem Lab | 2,732.30 | 32,664.65 | 6,677.08 | 1,264.42 | 7,728.19 |
Abbott India | 14,395.00 | 30,589.38 | 4,093.14 | 592.93 | 2,691.43 |
Glaxosmi. Pharma | 1,473.00 | 24,954.09 | 3,224.68 | 110.05 | 2,129.60 |
Ipca Labs. | 1,859.80 | 23,591.56 | 4,367.43 | 652.46 | 4,185.23 |
Syngene Intl. | 562.60 | 22,504.00 | 2,011.90 | 411.50 | 3,313.70 |
Pfizer | 4,581.10 | 20,958.53 | 2,151.65 | 509.13 | 3,534.54 |
Dr Lal Pathlabs | 2,301.00 | 19,176.53 | 1,273.60 | 223.18 | 1,106.64 |
Laurus Labs | 357.20 | 19,167.35 | 2,797.34 | 267.05 | 2,966.39 |
Quick Links for Siris:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices